BUSINESS

Drugmaker Pfizer High On Sales

Pfizer Inc., the American multinational pharmaceutical and biotechnology corporation has seen its sales double in the fourth quarter.

With the global demand for the COVID-19 vaccine, the company continues to ride the wave in sales.

According to press reports, the company posted revenue of $23.8 billion, albeit missing analysts’ projections of $24.1 billion.

The company’s vaccine unit accounted for $13.9 billion, more than half of its total sales.

The company also reported a net income of $3.4 billion, topping analysts’ forecasts.

Pfizer said it expects $32 billion in sales this year from the COVID-19 vaccine, Comirnaty.

Readers Bureau, Contributor

Edited by Jesus Chan

Do you want to add feedback to this story?

Please add a comment in the box below or send an email to info@thereadersbureau.com,  Call us at 201-500-7715 Support the Readers Bureau https://www.bonfire.com/welcome/7abd26521f724/